Form 4 for ABUS Arbutus Biopharma Corp
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-04 · accession 0001447028-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | 2025-02-04 | ABUS | HASTINGS DAVID C | CFO | S - Sale | $3.28 | -22.2K | 159.7K | -12% | -$72.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-04 | S | D | 22,183 | $3.28 | 159,724 | D | — | — |